-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II Clinically Relevant Abstract

Symposia: Acute Lymphoblastic Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Fadi G. Haddad, MD1*, Elias Jabbour2, Nicholas J. Short, MD1, Nitin Jain, MD1, Xuelin Huang, PhD3*, Guillermo Montalban-Bravo, MD1, Tapan M. Kadia, MD1, Naval Daver, MD1, Cedric Nasnas1*, Ejiroghene Mayor4*, Patrice Eric Nasnas, MD4*, Wuliamatu Deen5*, Marianne Zoghbi1*, Jennifer Thankachan4*, Christopher Loiselle, BS5*, Rebecca Garris1*, Farhad Ravandi, MD, MBBS6 and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6MD Anderson Cancer Center, Houston, TX

Rachel Harris1*, Olga Taylor1*, Melanie Brooke Bernhardt, MS, PharmD1*, Ashley Chavana1*, Mark Zobeck, MD, MPH2*, Philip J. Lupo, PhD3*, Karen R. Rabin, MD, PhD4, Michael E. Scheurer, PhD5 and Austin L Brown, PhD1*

1Baylor College of Medicine, Houston, TX
2Department of Pediatrics, Division of Hematology-Oncology, Baylor College of Medicine, Houston
3Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX
4Department of Pediatrics, Baylor College of Medicine, Baylor College of Medicine TX Children's Cancer Center, Houston, TX
5Department of Pediatrics, Baylor College of Medicine, Houston, TX

Hong De Sa, MD1, Thomas G Deloughery, MD2, Curtis A Lachowiez, MD3, Jessica T. Leonard, MD4, Sven R. Olson, MD5, Joseph J. Shatzel, MD5, Ronan T. Swords, MD, PhD, FRCP, FRCPath6, Elie Traer, MD, PhD7 and Brandon Hayes-Lattin, MD8

1Division of Hematology & Medical Oncology, Oregon Health & Science University, Vancouver, WA
2Division of Hematology and Medical Oncology, Oregon Health and Science Univ., Portland, OR
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR
4Department of Hematology & Medical Oncology, Oregon Health and Science University, Portland, OR
5Oregon Health & Science University, Portland, OR
6Knight Cancer Institute, Oregon Health and Science University, Portland, OR
7Knight Cancer Institute, Oregon Health & Sciences University, Portland, OR
8Knight Cancer Institute, Oregon Health Science University, Portland, OR

Vivian Irizarry Gatell, MD1, Denise Kalos2*, Joseph A. Pidala, MD1, Hany Elmariah, MD, MS1, Farhad Khimani, MD1*, Asmita Mishra, MD, MBA1, Taiga Nishihori, MD1, Michael D. Jain, MD, PhD1, Michael Neider, MD1*, Lia Perez, MD1*, Sayeef Mirza, MD, MPH1, Bijal D. Shah, MD1, Leidy Lismeris Isenalumhe, MD, MS3, Nelli Bejanyan, MD1, Aleksandr Lazaryan, MD, MPH, PhD1 and Rawan Faramand, MD1

1Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
2Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
3Moffitt Cancer Center, Tampa, FL

Lucy Alderson1*, Lucy Waller1*, Mario Cortina Borja2*, Amy A Kirkwood3*, Vickaynne Carruthers4*, David Jamieson5*, Pam Kearns, MBChB, PhD, FRCPC6*, Amrana Qureshi7*, Susan Baird8*, Jayashree Motwani9*, Rachael Hough, MD10*, John Moppett11*, Ajay Vora, MD12, Gareth Veal, PhD4* and Sujith Samarasinghe13*

1Great Ormond Street Hospital, London, United Kingdom
2Institute of Child Health, London, United Kingdom
3Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom
4Newcastle University, Newcastle, United Kingdom
5NICR, Newcastle, GBR
6Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
7John Radcliffe, Oxford, United Kingdom
8Royal Hospital for Children and Young People, Edinburgh, United Kingdom
9Birmingham Children's Hospital, Birmingham, GBR
10UCLH, London, GBR
11Bristol Children's Hospital, Bristol, United Kingdom
12Great Ormond Street Hospital, London, GBR
13Great Ormond Street Hospital, London,, United Kingdom

Fausto Alfredo Rios Olais1, Fernando Gil-Lopez, MD2*, Analy Mora3*, Jessica Zalapa, MD4, Guillermo Rosales-Sotomayor, MD5*, Alejando Gabutti-Thomas, MD6* and Roberta Demichelis, MD7

1Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico
2Internal Medicine Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
3Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad Hidalgo, Mexico
4Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, MEXICO, MEX
5Gastroenterology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
6Radiology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
7Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Jessica Zalapa, MD1, Fausto Alfredo Rios Olais2, Fernando Gil-Lopez, MD3*, Analy Mora4*, Eduardo Gutiérrez-León3* and Roberta Demichelis, MD5

1Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, MEXICO, MEX
2Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Tlalpan, Mexico
3Internal Medicine Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
4Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad Hidalgo, Mexico
5Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Stephen J. Wicks, PhD1*, Marissa Younan2*, Trilochan Sahoo2*, Jen Hauenstein2*, Anusha Mylavarapu2*, Beth Matthews2*, Karine Hovanes2*, Meena Naik3*, Nishit Ojha3*, Amey Panchal3*, Yesheswini Naik3*, Rahul Arora3*, Vishwadeep Khushoo3*, Vasu Babu3*, Nishad Dhakate3*, Poonam Jain3*, Punit Jain3*, Govind Babu3*, Sandeep Rao3* and Sachin Jadhav, MD, MBBS, DM4

1Bionano, Denver, CO
2Bionano, San Diego, CA
3HealthCare Global, Bangalore, India
4HealthCare Global, Bengaluru, India

Matteo Dragani, MD1*, Roberta Agrippino, MD2*, Giovanna Rege Cambrin, MD, PhD3*, Matteo Leoncin, MD4*, Marco Cerrano, MD5*, Prassede Salutari, MD6*, Antonino Mulè, MD7*, Cristina Papayannidis, MD8, Marzia Defina, MD9*, Giulia Rivoli, MD10*, Elisabetta Todisco, MD, PhD11*, Elisabetta Abruzzese, MD12, Michele Cedrone, MD13*, Nicola Fracchiolla, MD14*, Fabio Guolo, MD, PhD15*, Giuseppe Lanzarone, MD16*, Robin Foà, MD17* and Sabina Chiaretti, MD, PhD18

1Hematology and Cellular Therapy Division, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Genova, Italy
2Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy., Rome, Italy
3Division of Internal Medicine and Hematology, San Luigi Gonzaga Hospital, Orbassano, Italy
4Hematology Unit, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia-Mestre, Italy
5Hematology Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Turin, Turin, Italy
6Department of Hematology, Ospedale Civile Spirito Santo, Pescara, Pescara, Italy
7UOC di Oncoematologia,, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
8Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy
9Hematology, Azienda Ospedaliera Universitaria Senese, Siena, Italy
10Hematology and Cellular Therapy Division, IRCCS Ospedale Policlinico San Martino, Genova, Genova, Italy
11Onco-Hematology Division, IEO, European Institute of Oncology IRCCS, Milan, Milan, Italy
12Department of Hematology, S Eugenio Hospital, Tor Vergata University, Roma, I, Italy
13UOC Ematologia, Azienza Ospedaliera San Giovanni Addolorata, Rome, Italy
14Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy
15Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
16Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Turin, Italy
17Division of Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
18Division of Hematology, Department of Translational and Precision Medicine, Division of Hematology, Rome, Italy

Kathy Yuen Yee Chan, PhD1*, Jiaoyang Cai, PhD2, Yu Liu, PhD3*, Jun J. J. Yang, PhD4, Ching-Hon Pui, MD4, Shuhong Shen, MD, PhD3, Chi Kong Li1 and Kam Tong Leung1*

1Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong
2Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology & Oncology, Shanghai Children's Medical Center, Shanghai, China
3Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology & Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
4Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

Seth E. Karol, MD1, Haitao Pan, PhD2*, Zhou Yinmei2*, Jeffrey E. Rubnitz, MD, PhD3, Nickhill Bhakta, MD, MPH4*, Sima Jeha, MD4, Mary V. Relling, PharmD5*, Kristine R Crews, PharmD5*, John C Panetta5*, Cara Morin, MD, PhD6*, Cheng Cheng2*, Ching-Hon Pui, MD3, Hiroto Inaba, MD, PhD3 and M Beth McCarville7*

1Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
2Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
3Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
4Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN
5Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
6Department of Pediatric Radiology, Cincinnati Children’s Hospital, Cincinnati, OH
7Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, TN

Jennifer J. Huang, MD, PhD1,2, Jacob S. Appelbaum, MD, PhD1,2, Kathryn Russell, ARNP1,2*, Carole Shaw1*, Ashley M. Eckel, MD, PhD2*, Xueyan Chen, MD, PhD1,2*, Rutu D. Vyas, CRA1*, Paul C. Hendrie, MD, PhD1,2*, Anna B. Halpern, MD1,2, Raya Mawad, MD1,2, Ryan D Cassaday, MD1,2, Roland B. Walter, MD, PhD, MS1,2, Mary-Elizabeth M. Percival, MD1,2 and Cristina Maria Ghiuzeli, MD1,2

1Fred Hutchinson Cancer Center, Seattle, WA
2University of Washington, Seattle, WA

Kirsten Thus, MD, PhD1*, Hester A. de Groot-Kruseman, PhD1*, Pauline Winkler-Seinstra, Drs.1*, Heidi Segers2*, Cor van den Bos, Dr.1,3*, Inge M. Van Der Sluis, Dr.1,4, Wim Tissing, Dr.1,5*, Margreet A. Veening, Dr.1,6*, Michel C. Zwaan, Prof. Dr.7,8*, Marta F. Fiocco, Prof. Dr.1,9,10*, Cornelis van Tilburg, Dr.11,12,13,14,15*, Rob Pieters, MD, PhD, MSc1 and Marc Bierings, MD16

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Department of Pediatric Oncology, UZ Leuven, Leuven, Belgium
3Department of Pediatric Oncology, Emma Children’s Hospital, Amsterdam, Netherlands
4Department of Pediatric Oncology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, Netherlands
5Univ. Medical Ctr. Groningen, Groningen, NLD
6Department of Pediatrics, Division of Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands
7Department of Pediatric Oncology, Erasmus MC/Sophia Children's Hospital, Rotterdam, Netherlands
8Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands
9Mathematical Instit, Leiden University, Leiden, Netherlands
10Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands
11Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
12Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany
13Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany
14German Cancer Consortium (DKTK), Heidelberg, Germany
15National Center for Tumor diseases (NCT), Heidelberg, Germany
16Princess Máxima Center, University Hospital for Children, Utrecht, Netherlands

*signifies non-member of ASH